Antonio Garcia Guiñon
Degree: Graduate
973 705351
agarciag.lleida.ics(ELIMINAR)@gencat.cat
Groups
Publications
-
Oñate G; Pratcorona, M; Garrido, A; Artigas-Baleri, A; Bataller, A; Tormo, M; Arnan, M; Vives, S; Coll, R; Salamero, O; Vall-Llovera, F; Sampol, A; Garcia, A; Cervera, M; Avila, SG; Bargay, J; Ortin, X; Nomdedeu, JF; Esteve, J; Sierra, J
Survival improvement of patients with FLT3 mutated acute myeloid leukemia: results from a prospective 9 years cohort.
Blood Cancer Journal 13 69-69. .
-
Diaz-Santa, J; Rodriguez-Romanos, R; Coll, R; Osca, G; Pratcorona, M; Gonzalez-Bartulos, M; Garrido, A; Angona, A; Talarn, C; Tormo, M; Arnan, M; Vives, S; Salamero, O; Tuset, E; Lloveras, N; Diez, I; Zamora, L; Bargay, J; Sampol, A; Cruz, D; Vila, J; Sitges, M; Garcia, A; Vall-Llovera, F; Esteve, J; Sierra, J; Gallardo, D
5 '-nucleotidase, cytosolic II genotype, and clinical outcome in patients with acute myeloid leukemia with intermediate-risk cytogenetics
EUROPEAN JOURNAL OF HAEMATOLOGY 109 755-764. .
-
Gonzalez J; Jatem E; Roig J; Valtierra N; Ostos E; Abo A; Santacana M; Garcia A; Segarra A
Usefulness of urinary biomarkers to estimate the interstitial fibrosis surface in diabetic nephropathy with normal kidney function.
NEPHROLOGY DIALYSIS TRANSPLANTATION 37 2102-2110. .
-
Moreno, DF; Clapes, V; Soler, JA; Gonzalez-Montes, Y; Gironella, M; Motllo, C; Granell, M; Abella, E; Garcia-Pintos, M; Garcia-Guinon, A; Cabezudo, E; Blade, J; Rosinol, L
Real-World Evidence of Daratumumab Monotherapy in Relapsed/Refractory Multiple Myeloma Patients and Efficacy on Soft-Tissue Plasmacytomas
Clinical Lymphoma Myeloma & Leukemia 22 635-642. .
-
Encinas, C; Hernandez-Rivas, JA; Oriol, A; Rosinol, L; Blanchard, MJ; Bellon, JM; Garcia-Sanz, R; de la Rubia, J; de la Guia, AL; Jimenez-Ubieto, A; Jarque, I; Inigo, B; Dourdil, V; de Arriba, F; Perez-Avila, CC; Gonzalez, Y; Hernandez, MT; Bargay, J; Granell, M; Rodriguez-Otero, P; Silvent, M; Cabrera, C; Rios, R; Alegre, A; Gironella, M; Gonzalez, MS; Sureda, A; Sampol, A; Ocio, EM; Krsnik, I; Garcia, A; Garcia-Mateo, A; Soler, JA; Martin, J; Arguinano, JM; Mateos, MV; Blade, J; San-Miguel, JF; Lahuerta, JJ; Martinez-Lopez, J
A simple score to predict early severe infections in patients with newly diagnosed multiple myeloma
Blood Cancer Journal 12 -. .
-
Bataller, A; Garrido, A; Guijarro, F; Oñate G; Diaz-Beya, M; Arnan, M; Tormo, M; Vives, S; de Llano MPQ; Coll, R; Gallardo, D; Vall-Llovera, F; Escoda, L; Garcia-Guinon, A; Salamero, O; Sampol, A; Merchan, BM; Bargay, J; Castaño-Díez S; Esteban, D; Oliver-Caldes, A; Rivero, A; Mozas, P; Lopez-Guerra, M; Pratcorona, M; Zamora, L; Costa, D; Rozman, M; Nomdedeu, JF; Colomer, D; Brunet, S; Sierra, J; Esteve, J
European LeukemiaNet 2017 risk stratification for acute myeloid leukemia: validation in a risk-adapted protocol.
Blood Advances 6 1193-1206. .
-
Onate, G; Bataller, A; Garrido, A; Hoyos, M; Arnan, M; Vives, S; Coll, R; Tormo, M; Sampol, A; Escoda, L; Salamero, O; Garcia, A; Bargay, J; Aljarilla, A; Nomdedeu, JF; Esteve, J; Sierra, J; Pratcorona, M
Prognostic impact of DNMT3A mutation in acute myeloid leukemia with mutated NPM1
Blood Advances 6 882-890. .
-
Ribera, JM; Morgades, M; Genesca, E; Chapchap, EC; Montesinos, P; Acuna-Cruz, E; Gil, C; Garcia-Cadenas, I; Barba, P; Gonzalez-Campos, J; de Llano, MPQ; Torrent, A; Ribera, J; Granada, I; Bernal, T; Diaz-Beya, M; Amigo, ML; Coll, R; Tormo, M; Vall-llovera, F; Gomez-Centurion, I; Sanchez-Sanchez, MJ; Soria, B; Cladera, A; Artola, MT; Garcia-Guinon, A; Gimenez-Conca, A; Amador, ML; Martinez-Sanchez, P; Algarra, JL; Vidal, MJ; Alonso, N; Maluquer, C; Llorente, L; Garcia-Boyero, R; Ciudad, J; Feliu, E; Orfao, A; PETHEMA Grp
Outcomes and prognostic factors of adults with refractory or relapsed T-cell acute lymphoblastic leukemia included in measurable residual disease-oriented trials
HEMATOLOGICAL ONCOLOGY 39 529-538. .
-
Genesca, E; Morgades, M; Gonzalez-Gil, C; Fuster-Tormo, F; Haferlach, C; Meggendorfer, M; Montesinos, P; Barba, P; Gil, C; Coll, R; Moreno, MJ; Martinez-Carballeira, D; Garcia-Cadenas, I; Vives, S; Ribera, J; Gonzalez-Campos, J; Diaz-Beya, M; Mercadal, S; Artola, MT; Cladera, A; Tormo, M; Bermudez, A; Vall-llovera, F; Martinez-Sanchez, P; Amigo, ML; Monsalvo, S; Novo, A; Cervera, M; Garcia-Guinon, A; Ciudad, J; Cervera, J; Hernandez-Rivas, JM; Granada, I; Haferlach, T; Orfao, A; Sole, F; Ribera, JM
Adverse prognostic impact of complex karyotype (>= 3 cytogenetic alterations) in adult T-cell acute lymphoblastic leukemia (T-ALL)
LEUKEMIA RESEARCH 109 -. .
-
Cejalvo, MJ; Bustamante, G; Gonzalez, E; Vazquez-Alvarez, J; Garcia, R; Ramirez-Payer, A; Perez-Persona, E; Abella, E; Garzon, S; Garcia, A; Jarque, I; Gonzalez, MS; Sampol, A; Motllo, C; Marti, JM; Alcala, M; Duro, R; Gonzalez, Y; Sastre, JL; Sarra, J; Lostaunau, G; Lopez, R; de la Rubia, J
Treatment patterns and outcomes in real-world transplant-ineligible patients newly diagnosed with multiple myeloma
ANNALS OF HEMATOLOGY 100 1769-1778. .
-
Ribera, JM; Morgades, M; Ciudad, J; Montesinos, P; Esteve, J; Genesca, E; Barba, P; Ribera, J; Garcia-Cadenas, I; Moreno, MJ; Martinez-Carballeira, D; Torrent, A; Martinez-Sanchez, P; Monsalvo, S; Gil, C; Tormo, M; Artola, MT; Cervera, M; Gonzalez-Campos, J; Rodriguez, C; Bermudez, A; Novo, A; Soria, B; Coll, R; Amigo, ML; Lopez-Martinez, A; Fernandez-Martin, R; Serrano, J; Mercadal, S; Cladera, A; Gimenez-Conca, A; Penarrubia, MJ; Abella, E; Vall-llovera, F; Hernandez-Rivas, JM; Garcia-Guinon, A; Bergua, JM; de Rueda, B; Sanchez-Sanchez, MJ; Serrano, A; Calbacho, M; Alonso, N; Mendez-Sanchez, JA; Garcia-Boyero, R; Olivares, M; Barrena, S; Zamora, L; Granada, I; Lhermitte, L; Feliu, E; Orfao, A
Chemotherapy or allogeneic transplantation in high-risk Philadelphia chromosome-negative adult lymphoblastic leukemia
Blood 137 1879-1894. .
-
Cabezón M; Malinverni R; Bargay J; Xicoy B; Marcé S; Garrido A; Tormo M; Arenillas L; Coll R; Borras J; Jiménez MJ; Hoyos M; Valcárcel D; Escoda L; Vall-Llovera F; Garcia A; Font LL; Rámila E; Buschbeck M; Zamora L
Different methylation signatures at diagnosis in patients with high-risk myelodysplastic syndromes and secondary acute myeloid leukemia predict azacitidine response and longer survival.
Clinical Epigenetics 13 9-9. .
